WuXi Testing

WuXi Testing is the Laboratory Testing Division of WuXi AppTec, serving as a comprehensive and integrated testing platform for drug and medical device development. The division provides a full spectrum of services including toxicology, drug metabolism and pharmacokinetics (DMPK), bioanalysis, and pharmacology to support global pharmaceutical and biotechnology partners. With major facilities in China and the United States, WuXi Testing enables clients to accelerate their R&D programs from early discovery through clinical development and regulatory submission. Its flagship 'WIND' program integrates preclinical services to streamline the Investigational New Drug (IND) application process, offering end-to-end support for regulatory filings. As a key component of WuXi AppTec's integrated CRDMO model, the division supports thousands of customers in bringing innovative treatments to patients worldwide.